(Bloomberg) -- Lawyers for President Donald Trump and his sprawling business interests are heading to court this week in Florida for high-stakes hearings that follow a pair of major setbacks in their wave of multibillion-dollar lawsuits.Most Read from BloombergUS Strikes Iran in Escalating Campaign After Troops KilledThousands of Trucks Haul Iraq’s Oil Through Syria in Sign of Hormuz LegacyUS Strikes Iran to ‘Punish’ It for Attack That Killed 2 TroopsTrump Silent So Far on Iran Plans as US Death
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
On the latest episode of Equity, we debate whether Apple's lawsuit will cast over OpenAi's much-discussed plans to get into hardware and go public.
A parasite outbreak tied to Taylor Farms sends Walmart and Yum Brands shares lower while Sweetgreen rallies on relief.
(Bloomberg) -- Walmart Inc. said it has removed four bagged iceberg lettuce salad products manufactured by Taylor Farms as recalls tied to a cyclosporiasis outbreak expand. Most Read from BloombergFCC Near Rulings Against Disney Over ‘The View,’ TV LicensesTaylor Farms Pulls Mexican Lettuce as Parasite Cases RiseChip Stocks Slide Into Bear Market in AI Unwind: Markets WrapSpaceX Slump Wipes Out $1 Trillion in Market Value From PeakGoogle Gemini Launch Delayed as Tech Falls Short of Internal Goal
By Daniel Wiessner July 17 (Reuters) - A U.S. judge on Friday rejected a bid by 26 employees of Meta Platforms to block the tech giant from laying them off while they pursue claims that they were
NEW YORK, July 17 (Reuters) - A New York state judge dismissed a lawsuit by a former JPMorgan Chase banker who in graphic terms said his former supervisor coerced him into sex and demanded his
3M stock has more than doubled over the past three years, while current checks suggest the shares trade below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and also screen as undervalued on traditional earnings multiples. At the same time, a mixed broader valuation score and fresh legal action over PFAS chemicals mean the gap between price and estimated value is not a straightforward story. 3M has delivered a 103.6% return over the last three years, which puts...
There's a reason Costco will pretty much let you return any item at any time without a hassle. Costco has built its reputation on offering high-quality products at competitive prices, backed by strict supplier standards and careful product selection. The company knows its products have been ...
OpenAI’s struggles could cause the AI bubble to burst, bringing down with it much more than the company’s hardware division.
OpenAI says it sees no evidence supporting Apple's lawsuit over alleged trade-secret theft.
OpenAI plans a screen-free AI home device while Apple seeks an injunction that could delay its rollout.
OpenAI still plans a year-end device reveal, but Apple's lawsuit, ecosystem strength and rising component costs may complicate its hardware push.
July 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch of its newly approved breast cancer drug and treatment-tolerability concerns overshadowed the company's first U. Food and Drug Administration on Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.
The primary reason for the 12-state lawsuit is that a Paramount-WBD combination would curb entertainment content and distribution, putting the TV/movie marketplace into fewer hands. What's the fallout?
The product is expected to be OpenAI’s first physical AI device and a crucial milestone as the company moves forward with its IPO plans.
The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...
OpenAI has issued another statement on the lawsuit, this time suggesting it lacks merit.
Apple seeks damages and other legal remedies that could slow OpenAI's device development and hiring.
OpenAI says it takes Apple’s complaint seriously but questions whether the allegations have any merit.
There’s no sugarcoating it; getting laid off is awful. But if you've been following the news, it feels like tech workers are being laid off left and right. Here’s what one Reddit user, who was recently laid off from an account executive role at a tech company, had to say on the r/Layoffs subreddit: ...
This deal could seriously harm movie theatres.
(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se
Hachette, Cengage, Elsevier, and other publishers allege that Google trained its AI on copyrighted works without the necessary permissions.
(Update with the Justice Department's response to a request for comment in the third paragraph.)
Plaintiffs allege Meta's AI-assisted evaluation process was discriminatory.

Apple's lawsuit against OpenAI shows how important AI devices will be for the iPhone maker.
Stock Market Today: The Dow Jones index dropped Tuesday ahead of the June CPI inflation report. IBM stock plunged 23% on earnings.
Apple hit an all-time stock high after it filed one of its most aggressive lawsuits in years, and the market barely flinched. That disconnect between price and risk is exactly what most investors are not pricing in right now.
Apple almost never sues, so when Tim Cook personally greenlit a complaint accusing OpenAI of stealing trade secrets and smuggling hardware prototypes out the door, Wall Street and Silicon Valley both took notice. The question now is whether the case disrupts OpenAI's IPO plans before a single share is priced.
‘The bad blood between Apple and OpenAI plays into Google’s hands,’ says Paul Meeks, head of technology research at Freedom Capital Markets.